Array BioPharma appoints Jason Haddock CFO

Array BioPharma appoints Jason Haddock CFO

BOULDER -- Array BioPharma (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted... Read More

Thursday July 28, 2016 0 comments Tags: Boulder, Array BioPharma, Ron Squarer, Jason Haddock, David Horin

Array BioPharma submits New Drug Application for binimetinib to FDA

Array BioPharma submits New Drug Application for binimetinib to FDA

BOULDER -- Array BioPharma (Nasdaq:ARRY) announced it submitted a New Drug Application (NDA) to the FDA for binimetinib in patients with advanced NRAS -mutant melanoma. The submission is... Read More

Friday July 1, 2016 0 comments Tags: Boulder, Array BioPharma, Ron Squarer, binimetinib

Array BioPharma closes agreement with Pierre Fabre to commercialize cancer products

Array BioPharma closes agreement with Pierre Fabre to commercialize cancer products

BOULDER -- Array BioPharma Inc . (Nasdaq: ARRY) today announced closing a definitive agreement with France-based Pierre Fabre following approval of the agreement by the European Commission on... Read More

Monday December 21, 2015 0 comments Tags: Boulder, Array BioPharma, Pierre Fabre, binimetinib, encorafenib

Array BioPharma partners with Pierre Fabre to globally develop and market cancer drugs

Array BioPharma partners with Pierre Fabre to globally develop and market cancer drugs

BOULDER -- Array BioPharma Inc . (Nasdaq: ARRY) and France-based Pierre Fabre are collaborating to globally develop and commercialize Arrays late-stage novel oncology products, binimetinib and... Read More

Tuesday November 17, 2015 0 comments Tags: Boulder, Array BioPharma, Pierre Fabre, Ron Squarer, binimetinib, encorafenib

Array names Patricia Henahan company CFO

Array names Patricia Henahan company CFO

BOULDER -- Array BioPharma (Nasdaq: ARRY) today announced it has appointed Patricia Henahan to be the companys chief financial officer. Henahan has extensive experience in the... Read More

Tuesday September 8, 2015 0 comments Tags: Boulder, Array BioPharma, Patricia Henahan, Ron Squarer

N30 Pharmaceuticals appoints R. Michael Carruthers new CFO

N30 Pharmaceuticals appoints R. Michael Carruthers new CFO

BOULDER - N30 Pharmaceuticals Inc. , a clinical-stage pharmaceutical company focused on developing product candidates for cystic fibrosis, announced R. Michael Carruthers has been appointed... Read More

By: InnovatioNews Friday February 6, 2015 0 comments Tags: Array BioPharma, Boulder, Jon Congleton, N30 Pharmaceuticals, N91115

Array BioPharma to regain rights to cancer-fighting drug under agreement with Novartis International

Array BioPharma to regain rights to cancer-fighting drug under agreement with Novartis International

BOULDER - Array BioPharma Inc. (NASDAQ: ARRY) announced it has reached a definitive agreement with Novartis International Pharmaceutical Ltd. to regain full worldwide rights to binimetinib. ... Read More

By: InnovatioNews Thursday December 4, 2014 0 comments Tags: Array BioPharma, binimetinib, Boulder, Novartis, Ron Squarer

Array BioPharma appoints industry veteran Victor Sandor as new chief medical officer

Array BioPharma appoints industry veteran Victor Sandor as new chief medical officer

BOULDER - Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on developing targeted small molecule drugs to treat cancer patients, announced the appointment of Victor... Read More

By: InnovatioNews Wednesday September 17, 2014 0 comments Tags: Array BioPharma, Boulder, Dr. Victor Sandor, Ron Squarer